BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Arcion Therapeutics 

2400 Boston Street
Suite 330
Baltimore  Maryland  21224  U.S.A.
Phone: 410-522-8701 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





 Company News
Arcion Therapeutics Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain 1/4/2012 11:14:22 AM    More...
Arcion Therapeutics to Present ARC-4558 Phase 2b Data for the Treatment of Pain Associated With Painful Diabetic Neuropathy at Upcoming Medical Meetings 6/14/2011 9:07:06 AM    More...
Arcion Therapeutics Receives FDA Fast Track Designation for ARC-4558 for the Treatment of Pain Associated with Painful Diabetic Neuropathy 9/14/2010 7:53:40 AM    More...
Arcion Therapeutics' Topical Gel Candidate, ARC-4558, Demonstrates Significant Pain Reduction in Phase 2b Trial for Painful Diabetic Neuropathy (PDN) 7/20/2010 9:29:39 AM    More...
Anesiva, Inc. (ANSV) Stockholders Approved Merger With Arcion Therapeutics; Merger Remains Contingent on Other Closing Conditions 12/8/2009 6:56:29 AM    More...
Anesiva, Inc. (ANSV) and Arcion Therapeutics Announce Merger Agreement; Creates New Company Focused on Targeted Pain Therapeutics 8/5/2009 6:12:59 AM    More...
Arcion Therapeutics' Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy 5/7/2009 11:12:15 AM    More...
Arcion Therapeutics Raises $8.8 Million ''A'' Round 1/9/2008 7:39:57 AM    More...

//-->